1-Benzhydryl-3-cyclopropyl-3-fluoroazetidine hydrochloride 在
钯氮气 、 乙醚 作用下,
以
乙醇 为溶剂,
反应 5.0h,
以This furnished the product as an off white solid (3.00 g, 93%)的产率得到3-环丙基-3-氟氮杂环丁烷盐酸盐
[EN] PYRIDINE-2-AMIDES USEFUL AS CB2 AGONISTS<br/>[FR] PYRIDINE-2-AMIDES UTILES COMME AGONISTES DE CB2
申请人:HOFFMANN LA ROCHE
公开号:WO2014086806A1
公开(公告)日:2014-06-12
The invention relates to CB2 agonists of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.
The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.
[EN] 5,6-DISUBSTITUTED PYRIDINE-2-CARBOXAMIDES AS CANNABINOID RECEPTOR AGONISTS<br/>[FR] PYRIDINE-2-CARBOXAMIDES BISUBSTITUÉS EN 5,6 SERVANT D'AGONISTES DU RÉCEPTEUR CANNABINOÏDE
申请人:HOFFMANN LA ROCHE
公开号:WO2015150438A1
公开(公告)日:2015-10-08
The invention relates to a compound of formula (I) wherein R1 to R4 are defined as in the description and in the claims. The compound of formula (I) are agonists of the Cannabinoid Receptor 2 and are therefore useful in the treatment of various diseases such as pain, atherosclerosis, inflammation etc.
Thiazoles and pyrazoles useful as kinase inhibitors
申请人:Vertex Pharmaceuticals Inc.
公开号:US08268811B2
公开(公告)日:2012-09-18
The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.
THIAZOLES AND PYRAZOLES USEFUL AS KINASE INHIBITORS
申请人:Mortimore Michael
公开号:US20130116228A1
公开(公告)日:2013-05-09
The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention.